External Validation of a Multiplex Urinary Protein Panel for the Detection of Bladder Cancer in a Multicenter Cohort
Li-Mei Chen(University of Central Florida), Charles J. Rosser(Cedars-Sinai Medical Center), Yunfeng Dai(University of Florida), Ellen C. Zwarthoff(Erasmus MC), Steve Goodison(University Hospital of Wales), Cármen Jerónimo(Universidade do Porto), Tibor Szarvas(Semmelweis University), Lars Dyrskjøt(Aarhus University Hospital), Marta Sänchez‐Carbayo(Spanish National Cancer Research Centre), Rui Henrique(Universidade do Porto), Alexander S. Parker(Jacksonville College), Michael Borre(Aarhus University), Paul R. Young(Kent State University), Willemien Beukers(Erasmus University Rotterdam), T. Jaeger(University of Duisburg-Essen), Vinata B. Lokeshwar(Augusta University Health), Karl X. Chai(University of Central Florida), Myron Chang(University of Florida Health), Torben F. Ørntoft(Aarhus University Hospital), Shanti Ross(Florida Hospital Cancer Institute), Luis E. López(University of Miami), Virginia Urquidi(Florida Hospital Cancer Institute)
Cited by 65
Related Papers
Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer
|JAMA Oncology|2019|992
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
|European Urology|2017|793
CD44 cell adhesion molecules.
|Molecular Pathology|1999|667
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
|Cancer Cell|2016|654
PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia
|Nature Genetics|2019|616